Since late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and ...

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...

After some years of a thriving life sciences job market, the Maryland biotech industry has had more than 1,200 layoffs in the last year, according to the State of Maryland’s Work Adjustment and ...

Overall, biotech layoffs claimed at least 10,000 jobs within the sector last year, according to data compiled by BioPharma Dive. Many of those jobs were at smaller biotech companies more ...

In the first quarter of 2023, 56 biopharmas laid off staff—an 87% jump compared to 2022, when 30 companies reported layoffs for the same period, according to a Fierce Biotech analysis. | In the ...

Brian Buntz, the pharma and biotech editor at Drug Discovery & Development, says companies across the industry have contributed to biotech layoffs in early 2024, driven by factors ranging from ...

Officials with Arvinas, a New Haven-based biotechnology firm, announced Thursday that the company is laying off 131 workers at the end of June, including 92 in Connecticut. The company announced ...

The biotech index fund XBI has climbed nearly 9% so far in 2023 and is up 11.74% over the last six months, trading at $88.80 per share. At its peak on Feb. 5, 2022, the XBI was trading at $166.78.

Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs by Charlotte Schubert on December 27, 2022 at 7:53 am Share 8 ...

Gina Calvanese got laid off from Jounce Therapeutics, a struggling Cambridge biotech, in April but landed a higher-paying, six-figure administrative job at a Boston drug maker within days.